Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-003525
Filing Date
2013-01-17
Accepted
2013-01-17 17:05:44
Documents
1
Period of Report
2013-01-15

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c31061_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c31061_4x0.xml 4 13718
  Complete submission text file 0001209191-13-003525.txt   15257
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address
REYNOLDS FRANCIS (Reporting) CIK: 0001503383 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52089 | Film No.: 13535455